Jason Kidd Morning Report 11/18/2009 Wegener: Controversy “Unlike doctors who joined the Nazi Party to be allowed to practice, Wegener joined the movement.

Slides:



Advertisements
Similar presentations
These are actual cases to –Stimulate your reading –Test your knowledge of the material Look for the sound icon (usually in the top right portion of.
Advertisements

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Vasculitis Syndromes Polymyalgia Rheumatica,Giant Cell Arteritis, Wegener’s Granulomatosis, Polyarteritis Nodosa.
DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009.
Vasculitis Philip Seo, MD, MHS Co-Director, the Johns Hopkins Vasculitis Center Compassionate Allowances Outreach Hearing on Autoimmune Diseases 16 March.
Microscopic Polyangiitis Saori Kobayashi. Doll ’ s Festival : Mar 3.
Wegener’s Granulomatosis
1 Clinical Presentation of GPA Jessica Meikle E2-CBL 10/13/2011.
Case Presentation Dr Mohan Shenoy Consultant Paediatric Nephrologist Royal Manchester Children’s Hospital.
Treatment of Vasculitis: immunesuppressives and biologics
Resident Report Wegener’s Granulomatosis Small vessel vasculitis Typical areas affected are sinus, upper airway, lungs, kidney Progressive course.
Morning Report January 19 th, 2010 Jason Kidd.
Tuesday Clinical Case Conference Zae Kim. Therapy of ANCA-Associated Small Vessel Vasculitis.
Wegener’s Granulomatosis Kristine Scruggs AM Report 14 September 2009.
A case of haemoptysis ERWEB Case.
Blood Vessels. Pathology Congenital Anomalies Arteriosclerosis HTN Vasculitides ( inflammations) Aneurysms & Dissections Veins & Lymphatics Tumors.
Vasculitis Hisham Alkhalidi.
WEGENER’S GRANULOMATOSIS
Churg-Strauss Syndrome: Dispelling the Myths
Vascular Disorders Monique Killins Roll # 1043 Windsor University School of Medicine.
Painless Necrotizing Scleritis with Inflammation in Wegener’s Granulomatosis Divya Mutyala, M.D. Robert S. Feder, M.D. Feinberg School of Medicine Northwestern.
ANCA – Associated Vasculitis
WEGENER’S GRANULOMATOSIS L.Grcevska Department of Nephrology Faculty of Medicine Skopje, R.Macedonia.
Nephrology Diseases & Chemotherapy. Idiopathic Nephrotic Syndrome (NS) Caused by renal diseases that increase the permeability across the glomerular filtration.
Giant Cell Arteritis Julie Story July 27, Overview Typical case presentation Differential diagnosis Confirming the diagnosis Associated symptoms.
Vasculitis Vasculitis arises when immune system mistakenly attacks blood vessels. What causes this attack isn't fully known, but it can result from infection.
NEPHROLOGY PRESENTATION 28/3/2011. HISTORY  62 year male from Bethlehem referred with renal failure  1/12 ago: Constitutional complaints No clear focus.
Vasculitises. Outline Basics Small groups Review.
פרופ' נוויל ברקמן מכון הריאה ביה"ח האוניברסיטאי הדסה עין-כרם
Diagnostic Approach to Vasculitis
Interstitial nephritis associated with PostInfectious GN PRAET MARLEEN, MD, PhD UNIVERSITY HOSPITAL GHENT.
Radiology 08/12/ /25/2009.
RHEUMATOID VASCULITIS Kamal Kolappa UNC Internal Medicine Morning Report
Vasculitides constitute a spectrum of diseases characterized by inflammation & necrosis of blood vessels with resulting ischemia of those tissues.
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME UPDATE IN DIAGNOSIS.
Two Women with Hemoptysis Ellen Barbouche, MD Primary Care Conference 8 June 2005 NO FINANCIAL DISCLOSURE.
Vasculitis.
Renal involvement in Henoch-Schönlein purpura Anca Lupu 6 th year (Bagdasar Alina, Gabor Estera) – Faculty of Medicine Scientific supervisor: Associate.
Vasculitis Review: Intern Conference
Systemic Vasculitis: a clinical approach
Challenging issues about vasculitis
Dr. Zahoor 1. What is Vasculitis?  It is inflammatory disorder of blood vessels which causes endothelial damage.  Vasculitis is histological term describing.
Goodpasture’s Syndrome and Anti- GBM disease. Goodpasture’s Syndrome Introduction Concurrence of pulmonary hemorrhage and focal necrotizing glomerulonephritis.
Glomerular diseases typical case reports morphology Doc. MUDr. Zdeňka Vernerová, CSc., MUDr. Martin Havrda.
Update on vasculitis.
Henoch-Scholein Purpura. Introduction Systemic vasculitis with a prominent cutaneous component. Systemic vasculitis with a prominent cutaneous component.
Vasculitis Joanna Zalewska. Definition  Group of a rare conditions characterized by inflammation of blood vessels.
The Pulmonary Vasculitides
Granulomatosis with polyangiitis (GPA) is a systemic vasculitis that usually involves the lungs, upper respiratory tract and kidneys. Common presentations.
Recurrence of Henoch-Schonlein purpura nephritis after 6.5 years of remission- an unusual clinical occurrence Vignesh Pandiarajan*, Deepti Suri*, Anju.
“Monitoring Systemic Lupus Erythematosus” Andres Quiceno, MD Presbyterian Hospital of Dallas.
R2 정명화 Granulomatosis with polyangiitis (Wegener`s)
CASE Review. Current Problems Underlying Graves’ disease Administration of propylthiouracil Pancytopenia Hemoptysis Serology : ANA (+) Anti- Ro, Anti-
Vasculitis د فاخر يوسف.
Systemic vasculitis are heterogeneous group of diseases characterized by inflammation and necrosis of blood vessel wall , often associated with organ.
Lupus Nephritis Treatment
 Henoch-Schonlein Purpura
Rapidly progressive (crescentic) glomerulonephritis
Part 9A: Wegener’s Granulomatosis
Dr. Zahoor SYSTEMIC VASCULITIS.
Case Presentation Staci Smith DO April 17th, 2009.
Behcet’s Syndrome N.Movaffagh MD Rheumatologist
Henoch-Schönlein Purpura. WHAT IS Henoch-Schönlein Purpura  Also called anaphylactoid purpura  Henoch-Schönlein purpura (HSP) is the most common form.
IgA Nephropathy Southwest Nephrology Symposium February 24th 2018.
Giant Cell Arteritis and Polymyalgia Rheumatica Definition
Antineutrophil cytoplasmic antibody-associated vasculitis: Experience from Taichung Veterans General Hospital 施凱翔 梁凱莉 顏廷廷.
2016 합동집담회 증례 발표 서울대학교병원 영상의학과 유진영.
Utility of renal biopsy in the clinical management of renal disease
DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM
Algorithm based on the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of polymyalgia.
Presentation transcript:

Jason Kidd Morning Report 11/18/2009

Wegener: Controversy “Unlike doctors who joined the Nazi Party to be allowed to practice, Wegener joined the movement in 1932, before Hitler took power. He rose to a relatively high military rank and spent some of the war in a medical office three blocks from the Jewish ghetto in Lodz, Poland. Sketchy records suggest that he might have participated in experiments on concentration camp inmates.” Feder, NY Times 1/22/2008

Definition “A distinct clinicopathologic entity characterized by granulomatous vasculitis of the upper and lower respiratory tracts together with glomerulonephritis.” Harrison’s

Incidence and Prevalence Estimated prevalence: 3 per 100,000 1:1 male to female ratio Mean onset: 40 Harrison’s

Diagnostic Criteria: American College of Rheumatology proposed clinical criteria for diagnosis of WG: Nasal or oral inflammation Abnormal CXR Abnormal urinary sediment: hematuria with or without RBC casts Granulomatous inflammation on biopsy Adapted from UpToDate and Harrison’s

Diagnosis According to the Chapel Hill Consensus Conference: Granulomatous inflammation of respiratory tract Vasculitis of small to medium size vessels Jennette JC et al, Arthritis Rheum 1994

Upper Respiratory Tract Upper airway disease occurs in 90% of patients Nasal involvement may present with epistaxis, rhinorrhea, purulent discharge Otitis media and eustachian tube blockage can occur Nasal septal perforation may occur, leading to saddle nose deformity Subglottic tracheal stenosis can cause airway obstruction

Pulmonary Involvement Cough, hemoptysis, dyspnea Infiltrates and cavitary lesions can be seen on radiography Lung involvement typically appears as bilateral, nodular cavitary infiltrates Biopsy: necrotizing granulomatous vasculitis

Renal Involvement Generally manifested with acute renal failure Urine sediment: red cells, red cell casts, proteinuria Accounts for most of the mortality of this disease Renal biopsy: segmental necrotizing glomerulonephritis

Urine Sediment

Renal Biopsy

Laboratory tests Nonspecific Leukocytosis, thrombocytosis, elevated CRP, elevated ESR can all be seen 90-95% of patients with active Wegener’s are ANCA positive Diagnosis is confirmed by biopsy at site of active disease

Other Manifestations Joints: myalgias, arthralgias Eyes: episcleritis, uveitis Skin: palpable purpura, ulcerative lesions CNS: cranial nerve abnormalities Cardiac: pericarditis, coronary vasculitis High incidence of DVT

Treatment Diagnosis Remission Induction Remission maintenance Relapsing Disease Refractory Disease

Remission Induction Glucocorticoids Dosing has not been examined in randomized trials Generally start 1 mg/kg/day  mg daily at 12 weeks Cyclophosphamide Pulsed, IV is thought to be safer then oral Risk of myelosuppresion, infection, malignancy Plasma Exchange Shown in small studies to improve chances of renal recovery Recommended in lung hemorrhage Jayne, Nephrology 2009

Remission Maintenance Azathioprine or Methotrexate can be substituted for Cyclophosphamide after 3-6 months No standard length of treatment or regimen Relapses occur mostly in pt’s with continued ANCA positivity Relapse in WG has been assoc with nasal carriage of S. Aureus Utility of TMP/SMX prophylaxis? Jayne, Nephrology 2009

What happened? She received IV Cytoxan and Plex while hospitalized She has received a total of 3 doses of IV Cytoxan BAL grew Penicillium, currently being treated w/Vori She developed LE petechiae and RLE DVT She continues to be HD dependent

Sources Carruthers D et al, Evidence based management of ANCA vasculitis, Best Practice & Research Clinical Rheumatology 2009, 23: Feder B, A Nazi Past Casts a Pall on Name of Disease, New York Times, Jan Jayne D, Progress of treatment in ANCA-associated vasculitis, Nephrology 2009, 14: Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37: Jennette JC, Falk RJ, Small Vessel Vasculitis, New England Journal of Medicine, 1997, 21: Kasper et al, Harrison’s Principles of Internal Medicine, 2005 UpToDate 2009

Questions?

Anything is possible.